SCHEMBL30959903

SCHEMBL30959903

CC(C)[Si](C#Cc1c(F)ccc2cccc(-c3ncc4c(N5CC6CCC(C5)N6C(=O)OC(C)(C)C)nc(S(C)(=O)=O)nc4c3F)c12)(C(C)C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KRAS P01116 18/20 0.40
GPR119 Q8TDV5 1/20 0.37
JAK1 P23458 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31441816 1.00 KRAS (0.40) KRASGPR119JAK1
SCHEMBL25263610 1.00 KRAS (0.40) KRASGPR119JAK1
SCHEMBL30959949 0.89 KRAS (0.40) KRAS
SCHEMBL25307042 0.89 KRAS (0.40) KRAS
SCHEMBL31669685 0.89 GPR119 (0.36) KRASGPR119JAK1
SCHEMBL30841170 0.89 GPR119 (0.36) KRASGPR119JAK1
SCHEMBL25310284 0.89 KRAS (0.46) KRASGPR119JAK1
SCHEMBL30959907 0.89 KRAS (0.46) KRASGPR119JAK1
SCHEMBL31341506 0.88 KRAS (0.46) KRAS
SCHEMBL26119833 0.88 KRAS (0.46) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025053850-A1 COVALENT KRAS-BINDING COMPOUNDS FOR MEDICAL TREATMENT HYKU BIOSCIENCES INC. (US) 2025-03-13 WO disclosed
WO-2023141570-A9 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF KRAS ARVINAS OPERATIONS, INC. (US) 2024-06-27 WO disclosed